NEW YORK (GenomeWeb News) – InforSense said today that the University of Greifswald is using its GenSense software platform to handle quality control, analysis, and annotation for a genotyping study of the causes of various diseases.
The University, located in Germany's Baltic Sea region, will use the software to analyze data from study of 4,100 individuals who were genotyped with the Affymetrix Genome-Wide Human SNP Array 6.0.
The Study of Health in Pomerania, which includes phenotype data, is aimed at finding the genetic causes of complex diseases, including the susceptibility loci for several common diseases.
The GenSense platform enables customers to "automate their genotypic analysis and quality control and improve productivity, especially when data needs to be repeatedly reformatted and transformed for use with different studies and tools," Jonathan Sheldon, InforSense's chief scientific officer, said in a statement.
Financial terms of the agreement were not released.